The subject of the contract is: delivery of medicines in the drug program for the treatment of cystic fibrosis:
Package No. 1
1) Ivacaftorum 75 mg + Tezacaftorum 50 mg + Elexacaftorum 100 mg x 56 tabletek (Kaftrio), 182 op.
2) Ivacaftorum 150 mg x 28 tabletek (Kalydeco), 182 op.
Package No. 2
1) Tezacaftorum 100 mg + Ivacaftorum 150 mg x 28 tabletek (Symkevi), 126 op.
2) Tezacaftorum 50 mg + Ivacaftorum 75 mg x 28 tabletek (Symkevi), 63 op.
3) Ivacaftorum 150 mg x 28 tabletek (Kalydeco), 189 op.
The purchase is carried out as part of the B.112 Drug Program reimbursed by the National Health Fund entitled "Treatment of Cystic Fibrosis".
The order must be completed in accordance with the requirements set out in the SWZ and the Draft Provisions of the Agreement.
Package No. 1The subject of the contract is: delivery of medicines in the drug program for the treatment of cystic fibrosis:
Package No. 1
1) Ivacaftorum 75 mg + Tezacaftorum 50 mg + Elexacaftorum 100 mg x 56 tabletek (Kaftrio), 182 op.
2) Ivacaftorum 150 mg x 28 tabletek (Kalydeco), 182 op.
The purchase is carried out as part of the B.112 Drug Program reimbursed by the National Health Fund entitled "Treatment of Cystic Fibrosis".
The order must be completed in accordance with the requirements set out in the SWZ and the Draft Provisions of the Agreement.
Package No. 2The subject of the contract is: delivery of medicines in the drug program for the treatment of cystic fibrosis:
Package No. 2
1) Tezacaftorum 100 mg + Ivacaftorum 150 mg x 28 tabletek (Symkevi), 126 op.
2) Tezacaftorum 50 mg + Ivacaftorum 75 mg x 28 tabletek (Symkevi), 63 op.
3) Ivacaftorum 150 mg x 28 tabletek (Kalydeco), 189 op.
The purchase is carried out as part of the B.112 Drug Program reimbursed by the National Health Fund entitled "Treatment of Cystic Fibrosis".
The order must be completed in accordance with the requirements set out in the SWZ and the Draft Provisions of the Agreement.